# Alnylam’s heart drug troubles take center stage at a cardiology conference

> **Open Intelligence Dossier** · First detected: 2026-08-28 13:07 UTC · Category: Business

## Executive Summary
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Alnylam’s heart drug troubles take center stage at a cardiology conference&quot; is generating significant coverage in the Business category, with 9 articles from 7 distinct sources tracked by PULSE so far.


Outlets currently covering the story include HCPLive, BioSpace, Seeking Alpha and STAT. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| HCPLive | CARDIO-TTRansform: Eplontersen Misses Primary Endpoint in ATTR-CM | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxNa2o4U1ZBS0lTd2doT3doVF9sVzZlbHIzbnNqMjhobUNERGNsQ3ZYdWNSVExmRnpUQnlBNGRnT2pBMzRrTW1wUFJ2R1hqeGo2WnRkbWlqSTI3WjNNNUJfdjBGbVpTTnRXYjZpWFdMM1pWZ3psTTBMSzBZS1hmS3k2cmk3anBnd1IzVEY0ZDZaSXBZNGZFMUZyOQ?oc=5) |
| BioSpace | ‘Worse than expected’ Wainua data muddies water for TTR silencers | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNnh6bU1xc1g2R3JFVVVCRnpiRFJaYWdMbXVqZm9KbzlYRm1FQXRCNWZ0OFdzTk1EZHJFYjRUNFJ3b1lrcTZscjRtT0p6X1B0MjFZNXlyak00WHJ1YkdWb3dHd2szc1FCblRaZGFtZzJlNFEzeGsxU1dwYnBpZlJOYjNDbzFCOGU4SS16cFdmT2JlWW9MZ0NmaG1WQ1V6c3hpM2NFU1NZR3k?oc=5) |
| Seeking Alpha | Alnylam drops as AstraZeneca posts full trial results for failed heart drug | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQQUFQRmp0WmtZRy1jOVlyMlhDRFZmRnRLc3dmclNpMGlzNDY0OTg0RC1zNE5jd1pJWEVGSjk3MUdiTGMtMnFrSG1oYmh0bV8yY05hNnFhMGpRMVpJbGVSckNuc25BaDFNTGc0eGY2aFRUcTRCV2JjWHQyX3V5a3p2SmhXekN3TG9wLTJyYjNzMDBGOXlSWVUw?oc=5) |
| STAT | AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxOcldhVnY2RDgtTzFMdFNqQ2FKYml2R3FkVmM2UU5tYTROa1hwNFpRdzlkRUM3MG9iYmg3N0FtUUJReE9HYmZ4TVFLZlVNaVkxTGdBQ1c2Y0pHWFBMUEVsZDh6R003WkkxMURBLVFKZzhTaXBhOXduckd2TmRTaklNWXdVdTFPbEpoTC13T1pnOEEwVW1nWmRNNGhCWmt5S0E4bmFOVFRLQzFhWFc5SGMtRG9ocw?oc=5) |
| DirectorsTalk Interviews | Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with 56.72% Potential Upside | [Source Link](https://news.google.com/rss/articles/CBMi2wFBVV95cUxNRm5CNXlld0JlX0dYUG9FMHVkUl9qOHBOTjh5MU9keWlKRVlfNzQ1dHhJaGlmWUtmdU1QQ2kzSzNFQlFueFBvbFg4X2N4VDNwcVJKWGVIRlBzYmZZTklqNlBGaHUxOWo4dndnSXdabm5pRnVDcGxLbUZEeUhGbThBUHpsNndjck9UYXBiSXo4NFgyVzNxdF9YS0VwYXYtak9IcDc2ZmNMblJFanFMbnVOQW5tUW9FYS05Y0JCTFVHTWdvWVp4dy1WLUEzNWoxVU5QTUd4S3lWWmxtcU0?oc=5) |
| Yahoo Finance | Is Alnylam (ALNY) Turning Expanded HELIOS-B and Zilebesiran Data Into Durable Cardiovascular Leadership? | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxNZlRaZHFVWWZaUWMtMDNXVktkVGt5Wm82MDA3bkhwRkxqMDE5b2VZUS02U1VLdGhPemotdHJ2ZzBBZThURGttb1h5TGdoSXI2ZDJQVDFxV2NENU1NQ3ZLRXYtaUUtR1drR2NqRHprcXlJY1MySjE4cWV2N0tsalZTM291TWN1REJ1MU5pNGVTLW5nTUZVbmZUa25ZM2pjdw?oc=5) |
| Endpoints News | Future of AstraZeneca’s gene silencer in heart disease uncertain after trial failure | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxPakNrZmpLTy1pbFJHRUdtMU8yV29JWDNoUlROUWtidE50Uk1uQkVDaWkxMWVaMUs5MGxfVDctWWxqSE8zbExuNGtybEM3QW1QamJaeG9QNXVuY2dJQU45LWhTdFM3cDNHZ0hPVkVPMXRmNmx1b3FUNjZSUDJMSXl3aTlZM1JZenJKbktjSHhic1MxNWs1Z21jbHBKNlRWSGphYU00?oc=5) |
| STAT | In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxNSEE2dFdPQWRSY1g4dVROU283TjFpNUY1UEtYU0VabWVmRkZxYTg1NkJ0aF9vOHdSOS1EZFJnVU10X3RTa1l1dVNGQ2dQS3BEMHMzSHFiVXVpTnhIVTNZTGdfeTNrZ0wxNnZzMXpxZV9ZdUgwWFgycGFYX1FVZ2xLVmhuUVhFUU01bVZ4dFg1YzN4NmVtUUNVc0tBVzljMHFQVGx6YkRsWWJfdEtVaUJINXgySQ?oc=5) |
| STAT | Alnylam’s heart drug troubles take center stage at a cardiology conference | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxQQ2VzMjJUM2gyZU5GYmhkY2c1Y011WmczcVRjZktxNmlKSjI4WW12Xy0tR3ZId2QwVmt2SmJtQmozMW1jTU1EX3B0ZnEwT01kOFJueWFzY2RBNUFLYmZnOGZYMWszbFRKT242VVJ4NmgzUUZydFltVlNkTDZ6WVpEOWhzOTZqOU0?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-08-28/alnylam-s-heart-drug-troubles-take-center-stage-at-a-cardiology-conference*
